Skip to content
Back to Compounds

Magnesium

Also called Mg. Essential mineral (electrolyte).

At a glance5 outcomes graded

Evidence last reviewed Added to the site , updated 19 studies citedEditorial review: NootropicsWork Editorial TeamEducational, not medical advice
Magnesium: magnesium L-threonate, one salt form used in cognition studies; other forms existMg2+OHOHOHOHOHHOO−OO−O
Magnesium: magnesium L-threonate, one salt form used in cognition studies; other forms exist.C8H14MgO10Structure: PubChem CID 45489777, National Center for Biotechnology Information

Safety notes

Sources say these groups should be careful:

Read safety and interactions

Bottom line

Magnesium is a mineral used in hundreds of enzyme reactions [21]. Placebo-controlled trials found small or inconsistent self-reported sleep effects, mostly in older adults with sleep complaints [1][2][5]. Stress and memory evidence is thin [8][10]. Diarrhea is the main side effect; the supplement upper levels (350 mg US, 250 mg EU a day) are precautionary, set on mild diarrhea [20][21].

Key takeaways

  • In a university-funded trial of 155 adults reporting poor sleep, magnesium bisglycinate improved self-rated sleep scores slightly more than placebo over 4 weeks, a small effect [5].
  • A 2026 systematic review of 12 randomized trials found sleep results inconsistent across measures and rated the certainty of evidence low to very low [2].
  • Magnesium citrate dissolved better than oxide in a laboratory test and was absorbed better in studies in healthy volunteers, which did not measure sleep or mood [15][16].
  • The US upper level for magnesium from supplements is 350 mg a day for adolescents and adults, and diarrhea is the first sign of too much [20].
  • Magnesium can reduce absorption of tetracycline and quinolone antibiotics and oral bisphosphonates, while diuretics and proton pump inhibitors can lower magnesium [17][28].

New to Magnesium? Start with What is magnesium? A plain-English guide.

Evidence by outcome

Working memory

C, limited. Benefit foundEvidence maturity: Early signal

Trial evidence is insufficient Source [10].

3 studies linkedIndustry-funded
Why C, and history for Working memory

A 6-week Threotech-funded trial of magnesium L-threonate in 100 adults with dissatisfied sleep found a greater improvement on the NIH Total Cognition Composite (p = 0.043), with larger effects on working and episodic memory, but no difference on Raven's test. A second trial tested a multi-ingredient formula and was funded by the ingredient maker. A 2024 NIH-funded meta-analysis concluded RCT evidence was insufficient. With one funder, one product and an NIH-funded synthesis finding insufficient evidence, C is proposed.

Rubric condition met: C: one RCT of magnesium alone (n = 100, supplier-funded) plus one multi-ingredient RCT; an NIH-funded meta-analysis judged RCT evidence insufficient

Grade history

  • : Graded C (awaiting approval)
  • : C to C (awaiting approval). Maturity, bias summary and re-check date added
  • : C to C (approved). Editor sign-off November 16, 2026: grade matches the editor-approved final page

Studies and full rationale for Working memory

How sure are we? Working memory

Evidence maturity: Early signal One magnesium-alone RCT (n = 100, supplier-funded, magnesium L-threonate) and one multi-ingredient RCT.

Tested as: Magnesium L-threonate (Magtein)

Who paid for the studies
All industry-funded
Risk of bias
Some concerns. The 2026 review that rates certainty low to very low is led by an author of the Threotech-funded trial and co-author of the bisglycinate trial. A 2026 correction to the Magtein trial is logged; its content was not read.
Trial registry check
Not checked yet
Outcome measured
A test score, rating scale or performance measure
Who was studied
Matched
Material tested
Magtein (magnesium L-threonate)
Doses used in studies
2 g a day of magnesium L-threonate
Rules applied
B2: one funder or group (logged, no further change): One funder and one product
  • Could rise: Would move to B with a non-supplier replication of the Magtein trial, preregistered, with cognition as primary.
  • Could fall: Would move to C none with an adequately sized null replication.

Science is provisional. This grade reflects the evidence we found as of . Next review: .

Perceived stress

C, limited. No effect foundEvidence maturity: Early signal

The evidence is weak and comes from vulnerable groups Source [8]Source [9].

2 studies linkedSubjective outcome only
Why C, and history for Perceived stress

A 2017 systematic review of 18 studies, all in samples vulnerable to anxiety, found some positive effects on subjective anxiety but judged the evidence poor, and no included study used a validated stress measure. A 2018 stress trial (264 adults with high stress and low serum magnesium, Sanofi-funded) found stress scores fell by about 42-45% in both arms, but it had no placebo arm. The 2018 trial was funded by Sanofi, maker of the products tested; the review's funding is not stated.

Rubric condition met: C: no placebo-controlled trial with a validated stress measure; a 2018 stress trial compared two magnesium products without placebo; anxiety-vulnerable populations

Grade history

  • : Graded C (awaiting approval)
  • : C to C (awaiting approval)
  • : C to C (awaiting approval). Maturity, bias summary and re-check date added
  • : C to C (approved). Editor sign-off November 16, 2026: grade matches the editor-approved final page

Studies and full rationale for Perceived stress

How sure are we? Perceived stress

Evidence maturity: Early signal Small trials in adults with high stress and low serum magnesium, or anxiety-vulnerable samples.

Tested as: Magnesium (mostly bisglycinate and other salts)

Who paid for the studies
Mixed
Risk of bias
Some concerns
Trial registry check
Not checked yet
Outcome measured
A test score, rating scale or performance measure
Who was studied
Clinical populations only
  • Could rise: Would move to C benefit with a preregistered RCT positive on a validated stress primary.
  • Could fall: Would move to N with two adequately sized null RCTs.

Science is provisional. This grade reflects the evidence we found as of . Next review: .

Sleep latency

C, limited. Benefit foundEvidence maturity: Emerging

The pooled evidence comes from older adults and is weak Source [1].

3 studies linkedShort-term only
Why C, and history for Sleep latency

A 2021 meta-analysis of 3 RCTs in 151 older adults with insomnia found sleep onset latency 17.36 minutes shorter with magnesium than placebo, but all trials were at moderate-to-high risk of bias and the evidence was low to very low quality. One contributing trial had 46 older adults. A 2026 systematic review that included insomnia trials found results inconsistent across self-reported, EEG and actigraphy measures and rated certainty low to very low. No pooled estimate exists for healthy adults.

Rubric condition met: C: results only in older or clinical populations (older adults with insomnia), extrapolated to healthy adults

Grade history

  • : Graded C (awaiting approval)
  • : C to C (awaiting approval). Maturity, bias summary and re-check date added
  • : C to C (approved). Editor sign-off November 16, 2026: grade matches the editor-approved final page

Studies and full rationale for Sleep latency

How sure are we? Sleep latency

Evidence maturity: Emerging Two or more RCTs, mainly in older adults with insomnia.

Tested as: Magnesium (mostly bisglycinate and other salts)

Who paid for the studies
Mixed
Risk of bias
Some concerns
Trial registry check
Not checked yet
Outcome measured
A test score, rating scale or performance measure
Who was studied
Clinical populations only
Rules applied
Population cap (logged, no further change): Older adults with insomnia
  • Could rise: Would move to B with an independent preregistered RCT in healthy adults positive on sleep latency as primary.
  • Could fall: Would move to N with two adequately sized independent null RCTs.

Science is provisional. This grade reflects the evidence we found as of . Next review: .

Sleep quality

C, limited. Benefit foundEvidence maturity: Emerging

Evidence is mixed, with small effects at best Source [2]Source [5].

5 studies linkedSubjective outcome onlyShort-term only
Why C, and history for Sleep quality

The largest university-funded trial (magnesium bisglycinate, 155 adults reporting poor sleep; one author runs a contract research organization funded by nutraceutical companies) found a greater fall in Insomnia Severity Index score than placebo at week 4, with a small effect (d = 0.2, p = 0.049). A 2026 systematic review of 12 RCTs found inconsistent results across subjective and objective measures and rated certainty low to very low, concluding that current evidence does not support oral magnesium as a routine approach for people with insomnia. Two magnesium L-threonate trials were funded by ingredient suppliers, and the larger one found no ring-measured sleep differences. One large RCT could support a B, but the conflicting syntheses and mostly subjective outcomes keep this at C.

Rubric condition met: C: small or short trials with inconsistent results; a university-funded RCT (n = 155) showed a small, borderline effect, and a 2026 systematic review of 12 RCTs rated certainty low to very low

Grade history

  • : Graded C (awaiting approval)
  • : C to C (awaiting approval). Maturity, bias summary and re-check date added
  • : C to C (approved). Editor sign-off November 16, 2026: grade matches the editor-approved final page

Studies and full rationale for Sleep quality

How sure are we? Sleep quality

Evidence maturity: Emerging Two or more RCTs in adults reporting poor sleep, but no preregistered independent RCT positive on its primary could be confirmed; certainty low to very low.

Tested as: Magnesium (mostly bisglycinate and other salts)

Who paid for the studies
Mixed
Risk of bias
Some concerns. The 2026 review that rates certainty low to very low is led by an author of the Threotech-funded trial and co-author of the bisglycinate trial.
Trial registry check
Not checked yet
Outcome measured
A test score, rating scale or performance measure
Who was studied
Matched
Material tested
Largest trial: magnesium bisglycinate
Doses used in studies
250 mg elemental magnesium a day (bisglycinate) in the largest trial
  • Could rise: Would move to B with an independent preregistered RCT in 100 or more adults with poor sleep, positive on a prespecified sleep primary.
  • Could fall: Would move to N with two adequately sized independent RCTs null on the primary.

Science is provisional. This grade reflects the evidence we found as of . Next review: .

Strength and power output

N, no benefit shown. No effect foundEvidence maturity: Emerging

Not in athletes Source [14].

1 study linked
Why N, and history for Strength and power output

A 2017 meta-analysis of 14 RCTs found no significant improvements in isokinetic peak torque, muscle strength or muscle power, and concluded the evidence does not support a benefit for most athletes and physically active people. Benefits appeared more pronounced in older adults and people with alcoholism. The analysis used a fixed-effects model and is the only synthesis found; the N applies to athletes and physically active people.

Rubric condition met: N: meta-analysis of 14 RCTs found no significant pooled improvement in strength or power, and no benefit in athletes and physically active people

Grade history

  • : Graded N (awaiting approval)
  • : N to N (awaiting approval). Maturity, bias summary and re-check date added
  • : N to N (approved). Editor sign-off November 16, 2026: grade matches the editor-approved final page

Studies and full rationale for Strength and power output

How sure are we? Strength and power output

Evidence maturity: Emerging One fixed-effects meta-analysis of 14 RCTs; Established on counts only if an included trial is preregistered and independent, which was not checked.

Tested as: Magnesium (mostly bisglycinate and other salts)

Who paid for the studies
Not stated (treated as not independent)
Risk of bias
Not assessed
Trial registry check
Not checked yet
Outcome measured
A test score, rating scale or performance measure
Who was studied
Matched
  • Could rise: Would move to C benefit with two adequately sized independent RCTs positive on strength in people with low magnesium status.
  • Could fall: Already at N.

Science is provisional. This grade reflects the evidence we found as of . Next review: .

Maturity sits beside each grade. The grade says what the evidence shows; maturity says how much of it there is and how well it is confirmed.

Established
many trials from several independent teams, including at least one registered in advance
Emerging
two or more trials, or one large registered trial, not yet independently confirmed
Early signal
one trial, small pilots, or results only on secondary outcomes
Mechanistic only
lab, animal or biomarker data, or uncontrolled reports; no controlled human results
Traditional use only
a traditional-use monograph and nothing else

Grades describe evidence for each outcome, not a recommendation. Open “Why” on a card for its rationale and dated grade history. How we grade

Each section names the population studied, because many trials enrolled older adults, poor sleepers or people with low magnesium [1][5][9]. Our evidence grading method explains what each grade requires.

Does magnesium improve sleep quality?

Evidence is mixed, with small effects at best [2][5]. A 2026 systematic review of 12 randomized trials of magnesium alone in adults found that populations, forms, elemental doses, durations and measures varied substantially [2]. Results were inconsistent across self-reported sleep, EEG, actigraphy and consumer wearables, and the reviewers rated certainty low to very low [2]. They concluded that current evidence does not support oral magnesium as a routine approach for people with insomnia; it may give modest benefits on some self-reported outcomes in some adults, but findings are inconsistent [2]. An earlier systematic review of 9 observational studies and trials (7,582 participants) found observational studies linked magnesium status with sleep quality, while the trials were contradictory [3].

A 2025 trial found a small effect. In a university-funded, placebo-controlled trial of 155 healthy adults aged 18-65 reporting poor sleep, magnesium bisglycinate (250 mg elemental magnesium a day) lowered Insomnia Severity Index scores more than placebo by week 4 (-3.9 vs -2.3; p = 0.049) [5]. The authors described the effect as small (Cohen's d = 0.2), and other psychological outcomes did not differ [5]. Exploratory analyses in that trial suggested larger improvements in people with low dietary magnesium intake [5].

Two magnesium L-threonate trials were funded by ingredient suppliers [6][7]. In a trial funded by the ingredient supplier AIDP Inc., 80 adults aged 35-55 with self-reported sleep problems took 1 g a day for 21 days, which improved Oura ring deep sleep and REM sleep scores compared with placebo [6]. Part of the difference reflected worsening in the placebo group, which declined while the magnesium group held steady [6]. AIDP commissioned the study and owns patents, three authors are paid by AIDP, and a 2025 corrigendum states the trial was registered retrospectively, on April 15, 2024 [6]. In a trial funded by the ingredient supplier Threotech Inc., 100 adults aged 18-45 with dissatisfied sleep took 2 g a day for 6 weeks, which improved self-reported sleep-related impairment, but ring-measured sleep, sleep disturbances and restorative sleep did not differ from placebo [7].

Does magnesium help people fall asleep faster?

The pooled evidence comes from older adults and is weak [1]. A 2021 meta-analysis on insomnia in older adults pooled 3 placebo-controlled trials in 151 older adults and found people fell asleep 17.36 minutes sooner after magnesium than placebo [1]. Total sleep time rose by 16.06 minutes, but that difference was not statistically significant [1]. All three trials were at moderate-to-high risk of bias and the evidence was low to very low quality [1]. The authors called the literature substandard for well-informed recommendations [1].

One included trial had 46 older adults with primary insomnia, who received 500 mg magnesium or placebo daily for 8 weeks [4]. Compared with placebo, magnesium shortened sleep onset latency and improved sleep efficiency and Insomnia Severity Index scores, though total sleep time did not differ between groups [4]. Results may not apply to healthy adults.

The newer 2026 systematic review, which included trials in people with insomnia, found results inconsistent across self-reported, EEG and actigraphy measures and rated certainty low to very low [2].

Does magnesium reduce stress?

The evidence is weak and comes from vulnerable groups [8][9]. A 2017 systematic review found 18 studies, all in samples with an existing vulnerability to anxiety: mildly anxious adults, premenstrual syndrome, the postpartum period and hypertension [8]. Four of eight studies in anxious samples reported positive effects on self-rated anxiety, but no study used a validated measure of stress, and the authors judged the evidence poor [8]. One review author was a member of a Sanofi consumer healthcare advisory board when it was published [8].

A 2018 stress trial had no placebo arm [9]. In that Sanofi-funded, single-blind trial of 264 healthy adults with high stress scores and low serum magnesium, both 300 mg magnesium a day and the same dose plus 30 mg vitamin B6 cut stress scores by 42.4% and 44.9% over 8 weeks, with no difference between the arms [9]. Without a placebo group, the trial cannot separate magnesium's effect from time and expectation [9].

Does magnesium improve memory?

Trial evidence is insufficient [10]. A 2024 NIH-funded meta-analysis of 3 randomized trials and 12 cohort studies concluded the trial evidence was insufficient to judge magnesium supplements [10]. Its cohort studies found U-shaped links between blood magnesium and cognitive impairment, which is association, not effect [10].

The supplement trials were funded by ingredient makers [7][11]. In the trial of 100 adults with dissatisfied sleep funded by the ingredient supplier Threotech Inc., 2 g a day of magnesium L-threonate for 6 weeks improved an overall NIH cognition score more than placebo (p = 0.043), with larger effects on working and episodic memory, but showed no difference from placebo on Raven's reasoning test (p = 0.953) [7]. In a trial funded by Wu-xi Magtein Bioscience, 109 healthy Chinese adults took 2 g a day of a formula combining magnesium L-threonate with phosphatidylserine and vitamins C and D, or placebo, for 30 days; the formula group improved more on all five subtests of a memory test [11]. Because that company-funded formula had several ingredients, it cannot show what magnesium alone did [11].

Does magnesium improve strength or power?

Not in athletes [14]. A 2017 meta-analysis of 14 randomized trials found no significant improvements in peak torque, muscle strength or muscle power with magnesium [14]. The authors concluded the evidence does not support a benefit for most athletes and physically active people, and that benefits appeared more pronounced in older adults and people with alcoholism [14].

What the evidence does not show

Magnesium supplements are marketed for cramps [13], but a Cochrane review of 11 trials (735 people) found that magnesium is unlikely to reduce cramps in a clinically meaningful way in older adults who have them [13]. In trials of cramps without a clear cause, largely in older adults, differences in cramp frequency between magnesium and placebo were small and not statistically significant [13]. For cramps in pregnancy the review found the trials conflicting, and it found no randomized trials of exercise-associated cramps [13].

Doses used in studies

Ranges researchers used, not dosing advice. Bars share one scale. Read our disclaimer.

Sleep trials in older adults (pooled)320-729 mg elemental magnesium a day as oxide or citrate, 20 days to 8 weeks320 to 729 mg
Sleep trial in older adults with primary insomnia500 mg magnesium a day for 8 weeks500 mg
Sleep trial in adults reporting poor sleepMagnesium bisglycinate, 250 mg elemental magnesium a day250 mg
Magnesium L-threonate trials1-2 g a day of magnesium L-threonate (2 g provided 145 mg elemental magnesium), 21 days to 6 weeks

1-2 g a day of magnesium L-threonate (2 g provided 145 mg elemental magnesium), 21 days to 6 weeks

Stress trial (no placebo arm)300 mg magnesium a day, with or without 30 mg vitamin B6, 8 weeks300 mg
Bioavailability trial300 mg elemental magnesium a day for 60 days300 mg

Timing and form

Forms differ in how well they dissolve and are absorbed [15][16]. In a laboratory test, magnesium oxide was virtually insoluble in water and only 43% soluble in simulated stomach acid, while magnesium citrate was 55% soluble even in water [15]. After an oral load in volunteers, urinary magnesium rose more with citrate than with oxide, and the authors concluded citrate was more soluble and bioavailable [15]. In a 60-day randomized trial of 46 healthy adults taking 300 mg elemental magnesium a day, citrate and amino-acid chelate were absorbed better than oxide, and oxide produced no difference from placebo [16].

Those studies measured absorption, not sleep, stress or memory [15][16]. Sleep trials have used magnesium oxide and citrate [1], bisglycinate [5] and L-threonate (in supplier-funded trials) [6][7], and the 2026 review summarized the results narratively because the trials differed so much [2].

On timing, the supplier-funded L-threonate trials gave doses 2 hours before bedtime, in one case split with a morning dose [6][7]. These are trial protocols, not evidence that timing matters.

What it is

Magnesium is a mineral and a cofactor in hundreds of enzyme reactions, many of them involved in energy metabolism [21]. It is the fourth most abundant positively charged ion (cation) in the body and the second most abundant inside cells [21], and an adult body holds about 21-28 g of it [21].

Green leafy vegetables contain magnesium, as chlorophyll is a magnesium compound. Unpolished grains and nuts also contain magnesium [20]. The NHS suggests spinach, nuts and wholemeal bread [26]. UK reference amounts for adults aged 19 to 64 are 300 mg a day for men and 270 mg a day for women [26]. The US Daily Value (on the Supplement Facts labels) is 420 mg for adults and children 4 and older [22].

Supplements come in many forms. Australia's list of permissible medicine ingredients, for example, includes magnesium citrate, magnesium glycinate and magnesium L-threonate, each with its own conditions [27]. Labels and trials may give the weight of the whole compound or the elemental magnesium (the magnesium itself) it supplies; see doses used in studies.

How it may work (mechanism, not effect): magnesium acts as a natural NMDA-receptor antagonist and GABA agonist, and trial authors propose that it plays a role in sleep regulation [4]. In rats, raising brain magnesium with magnesium L-threonate improved learning and working memory [12]. Neither finding shows an effect in people.

Safety and interactions

What sources report. The US upper level for supplemental magnesium in adolescents and adults is 350 mg a day, based on diarrhea at 360 mg [20]. EFSA's upper level is 250 mg a day for readily dissociable salts and magnesium oxide in supplements, the dose up to which no laxative effect was seen [21]. Both levels are precautionary thresholds for mild, reversible diarrhea, not doses at which serious harm was seen [20][21]. The US upper level of 350 mg a day also applies in pregnancy [20] and breastfeeding [28]. High blood magnesium occurs mainly in people with impaired kidney function who take large amounts of nonfood magnesium, such as antacids [20].

Who sources say should be careful.

  • People with impaired kidney function. The National Academies identify impaired kidney function (EFSA: severely impaired kidney function) as a risk factor for high blood magnesium from nonfood magnesium [20][21].

  • Children. US upper levels for supplemental magnesium are 65 mg a day at ages 1-3 and 110 mg a day at ages 4-8 [20]. Australian rules for several magnesium salts say oral medicines must not be directed for infants under 12 months [27].

  • People taking tetracycline or quinolone antibiotics or oral bisphosphonates. Magnesium can reduce the absorption of these medicines [17][28].

  • People taking diuretics or PPIs. These medicines can lower magnesium; ODS lists them as affecting magnesium status [17][28]. ODS says people who take these and other medicines regularly should discuss their magnesium intake with their health care providers [28].

  • Anyone taking more than the upper levels, where diarrhea becomes more likely [20][21].

Magnesium from food has not been shown to cause harm, so upper levels apply to magnesium from supplements and medicines [20]. The US National Academies set the upper level for supplemental magnesium at 350 mg a day for adolescents and adults, including in pregnancy, based on mild diarrhea seen at 360 mg [20]; the NIH Office of Dietary Supplements (ODS) lists the same 350 mg for breastfeeding [28]. EFSA's Scientific Committee on Food set a lower upper level of 250 mg a day for readily dissociable magnesium salts and magnesium oxide in supplements, water or fortified food, noting that no laxative effects were seen up to that dose [21]. NHS advice says 400 mg or less a day from supplements is unlikely to cause harm, that more than 400 mg for a short time can cause diarrhea, and that the effects of long-term high doses are not known [26].

Diarrhea is the first sign of too much magnesium from supplements, sometimes with nausea and abdominal cramping [20]. In the Cochrane cramp trials, adverse events, mostly gastrointestinal such as diarrhea, affected 11% (10% on control) to 37% (14% on control) of people taking oral magnesium, while major adverse events and withdrawals did not differ from placebo [13]. In the Sanofi-funded stress trial, 12.1% and 17.4% of participants in the two magnesium arms had side effects possibly related to treatment [9].

High blood magnesium occurs mainly in people with impaired kidney function who take large amounts of nonfood magnesium, such as antacids [20]. ODS reports that very large doses of magnesium-containing laxatives and antacids, typically above 5,000 mg a day, have been linked to magnesium toxicity, including deaths [28]. EFSA notes that only a few cases of toxic levels have been published, mostly involving laxative or antacid use in single doses above about 2,500 mg [21].

Interactions sources report

Magnesium and many medicines share absorption and elimination pathways [17]. A pharmacology review reports that magnesium, calcium and zinc can interfere with gut absorption of tetracycline antibiotics, and that diuretics and proton pump inhibitors (PPIs) can cause magnesium loss [17].

The NIH Office of Dietary Supplements fact sheet names more medicines [28]. It reports that magnesium can form insoluble complexes with tetracyclines, such as doxycycline, and with quinolone antibiotics, such as ciprofloxacin and levofloxacin, and that magnesium-rich supplements or medicines can reduce the absorption of oral bisphosphonates, such as alendronate [28]. It also reports that loop diuretics such as furosemide and thiazide diuretics such as hydrochlorothiazide can increase magnesium loss in urine [28].

For PPIs, ODS reports that they can cause low blood magnesium when taken for prolonged periods, typically more than a year [28], and the pharmacology review also reports that they can cause magnesium loss [17]. The two meta-analyses are observational and very heterogeneous [18][19]. A meta-analysis of 9 observational studies (109,798 patients) found PPI use linked to a higher risk of low blood magnesium (pooled risk ratio 1.43) [18]. An updated meta-analysis of 15 studies (129,347 participants) found a similar pooled estimate (1.44) but very high heterogeneity, and concluded the link remained unclear [19].

These sources describe what has been reported, not what is right for any individual. If you take any of these medicines, talk to your doctor or pharmacist before combining them with magnesium.

Products containing it

Partner product: we earn a commission

Qualia Night

Contains this compound among other ingredients. Our review compares each dose with the doses used in studies.

Read our review
Partner product: we earn a commission

Qualia Mind 2.0

Contains this compound among other ingredients. Our review compares each dose with the doses used in studies.

Read our review

FAQ

Which forms of magnesium are absorbed better?

In a 60-day randomized trial of 46 healthy adults, magnesium citrate and amino-acid chelate were absorbed better than magnesium oxide [16]. Those studies measured absorption, not sleep or stress [15][16].

Does magnesium glycinate help with sleep?

One university-funded randomized trial in 155 adults reporting poor sleep found magnesium bisglycinate (250 mg elemental magnesium a day) lowered Insomnia Severity Index scores a little more than placebo by week 4 (-3.9 vs -2.3; p = 0.049), a small effect [5]. Other psychological outcomes did not differ [5].

What is magnesium L-threonate?

It is a magnesium compound that raised brain magnesium and improved learning and memory in rats [12]. The human trials of it cited here were funded by ingredient suppliers [6][7].

How much magnesium is too much?

The US upper level for supplemental magnesium is 350 mg a day for adolescents and adults [20]; EFSA's is 250 mg a day for readily dissociable salts and magnesium oxide [21]. Talk to a clinician about your own situation, especially if you have kidney problems [20].

References

  1. Mah J, Pitre T. Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis. BMC Complement Med Ther. 2021.PMID 33865376DOI 10.1186/s12906-021-03297-zTier 1, meta-analysis
  2. Lopresti AL, Smith SJ, Drummond PD. Magnesium Supplementation for Sleep in Adults: A Systematic Review of Randomized Controlled Trials. J Diet Suppl. 2026.PMID 42661485DOI 10.1080/19390211.2026.2719670Tier 1, systematic review
  3. Arab A, Rafie N, Amani R, et al. The Role of Magnesium in Sleep Health: a Systematic Review of Available Literature. Biol Trace Elem Res. 2023.PMID 35184264DOI 10.1007/s12011-022-03162-1Tier 1, systematic review
  4. Abbasi B, Kimiagar M, Sadeghniiat K, et al. The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. J Res Med Sci. 2012.PMID 23853635Tier 1
  5. Schuster J, Cycelskij I, Lopresti A, et al. Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial. Nat Sci Sleep. 2025.PMID 40918053DOI 10.2147/NSS.S524348Tier 1, controlled trial
  6. Hausenblas HA, Lynch T, Hooper S, et al. Magnesium-L-threonate improves sleep quality and daytime functioning in adults with self-reported sleep problems: A randomized controlled trial. Sleep Med X. 2024.PMID 39252819DOI 10.1016/j.sleepx.2024.100121Tier 1
  7. Lopresti AL, Smith SJ. The effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial. Front Nutr. 2025.PMID 41601871DOI 10.3389/fnut.2025.1729164Tier 1, controlled trial
  8. Boyle NB, Lawton C, Dye L. The Effects of Magnesium Supplementation on Subjective Anxiety and Stress-A Systematic Review. Nutrients. 2017.PMID 28445426DOI 10.3390/nu9050429Tier 1, systematic review
  9. Pouteau E, Kabir-Ahmadi M, Noah L, et al. Superiority of magnesium and vitamin B6 over magnesium alone on severe stress in healthy adults with low magnesemia: A randomized, single-blind clinical trial. PLoS One. 2018.PMID 30562392DOI 10.1371/journal.pone.0208454Tier 1, RCT
  10. Chen F, Wang J, Cheng Y, et al. Magnesium and Cognitive Health in Adults: A Systematic Review and Meta-Analysis. Adv Nutr. 2024.PMID 39009081DOI 10.1016/j.advnut.2024.100272Tier 1, meta-analysis
  11. Zhang C, Hu Q, Li S, et al. A Magtein®, Magnesium L-Threonate, -Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults. Nutrients. 2022.PMID 36558392DOI 10.3390/nu14245235Tier 1, RCT
  12. Slutsky I, Abumaria N, Wu LJ, et al. Enhancement of learning and memory by elevating brain magnesium. Neuron. 2010.PMID 20152124DOI 10.1016/j.neuron.2009.12.026Tier 1
  13. Garrison SR, Korownyk CS, Kolber MR, et al. Magnesium for skeletal muscle cramps. Cochrane Database Syst Rev. 2020.PMID 32956536DOI 10.1002/14651858.CD009402.pub3Tier 1, meta-analysis
  14. Wang R, Chen C, Liu W, et al. The effect of magnesium supplementation on muscle fitness: a meta-analysis and systematic review. Magnes Res. 2017.PMID 29637897DOI 10.1684/mrh.2018.0430Tier 1, meta-analysis
  15. Lindberg JS, Zobitz MM, Poindexter JR, et al. Magnesium bioavailability from magnesium citrate and magnesium oxide. J Am Coll Nutr. 1990.PMID 2407766DOI 10.1080/07315724.1990.10720349Tier 1, controlled trial
  16. Walker AF, Marakis G, Christie S, et al. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res. 2003.PMID 14596323Tier 1, RCT
  17. Gröber U. Magnesium and Drugs. Int J Mol Sci. 2019.PMID 31035385DOI 10.3390/ijms20092094Tier 1, narrative review
  18. Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W, et al. Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies. Ren Fail. 2015.PMID 26108134DOI 10.3109/0886022X.2015.1057800Tier 1, meta-analysis
  19. Liao S, Gan L, Mei Z. Does the use of proton pump inhibitors increase the risk of hypomagnesemia: An updated systematic review and meta-analysis. Medicine (Baltimore). 2019.PMID 30921222DOI 10.1097/MD.0000000000015011Tier 1, meta-analysis
  20. Institute of Medicine (National Academies). Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride, chapter 6: Magnesium (1997), doi:10.17226/5776. 1997.SourceTier 1
  21. European Food Safety Authority (Scientific Committee on Food). Tolerable Upper Intake Levels for Vitamins and Minerals: Opinion on the Tolerable Upper Intake Level of Magnesium (expressed September 26, 2001). 2006-02.SourceTier 1
  22. U.S. Government Publishing Office (Code of Federal Regulations). 21 CFR 101.9 Nutrition labeling of food (2025 edition), Daily Values table. Updated April 1, 2025.SourceTier 1
  23. U.S. Food and Drug Administration. Dietary Supplements. Updated October 1, 2024.SourceTier 1
  24. Health Canada (Natural and Non-prescription Health Products Directorate). Multi-vitamin/mineral supplements monograph. Updated June 26, 2026.SourceTier 1
  25. Department of Health and Social Care / Food Standards Agency (GOV.UK). Great Britain nutrition and health claims (NHC) register, spreadsheet of May 19, 2026. Updated May 19, 2026.SourceTier 1
  26. NHS. Vitamins and minerals: Others. Updated August 3, 2020.SourceTier 2
  27. Australian Government Department of Health, Disability and Ageing (Federal Register of Legislation). Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2026, F2026L01382. Updated October 13, 2026.SourceTier 1
  28. NIH Office of Dietary Supplements. Magnesium: Fact Sheet for Health Professionals (as archived). Updated January 6, 2026.SourceTier 2
Reviewed by NootropicsWork Editorial Team, editorial team. Checklist logged . Next review due . Report an error